N1-Methylpseudouridine and pseudouridine modifications modulate mRNA decoding during translation
The ribosome utilizes hydrogen bonding between mRNA codons and aminoacyl-tRNAs to ensure rapid and accurate protein production. Chemical modification of mRNA nucleobases can adjust the strength and pattern of this hydrogen bonding to alter protein synthesis. We investigate how the N1-methylpseudouridine (m<sup>1</sup>Ψ) modification, commonly incorporated into therapeutic and vaccine mRNA sequences, influences the speed and fidelity of translation. We find that m<sup>1</sup>Ψ does not substantially change the rate constants for amino acid addition by cognate tRNAs or termination by release factors. However, we also find that m<sup>1</sup>Ψ can subtly modulate the fidelity of amino acid incorporation in a codon-position and tRNA dependent manner in vitro and in human cells. Our computational modeling shows that altered energetics of mRNA:tRNA interactions largely account for the context dependence of the low levels of miscoding we observe on Ψ and m<sup>1</sup>Ψ containing codons. The outcome of translation on modified mRNA bases is thus governed by the sequence context in which they occur.
Authors
- Kristin S. Koutmou (ORCID: https://orcid.org/0000-0002-7763-9262)
- Pooja Srinivas (ORCID: https://orcid.org/0000-0001-7796-8827)
- C.M. Dunham (ORCID: https://orcid.org/0000-0002-8821-688X)
- Aaron T. Frank (ORCID: https://orcid.org/0000-0002-7782-2200)
- Lili Mitchell
- Indrajit Deb (ORCID: https://orcid.org/0000-0002-2722-582X)
- Bijoyita Roy (ORCID: https://orcid.org/0000-0003-1061-5482)
- Jeremy Monroe (ORCID: https://orcid.org/0000-0002-1901-8345)
- Daniel E. Eyler (ORCID: https://orcid.org/0000-0002-6425-9770)
- Abigail Bojanowski
Institutions
- New England Biolabs (United States) (US)
- Emory University (US)
- University of Michigan (US)
- Arrakis Therapeutics (United States) (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2024-09-16
- DOI
- https://doi.org/10.1038/s41467-024-51301-0
- Citations
- 41
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 9.35
Funders
- National Science Foundation
- Research Corporation for Science Advancement
- National Institutes of Health
- National Institute of General Medical Sciences